Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency

Journal of Lipid Research

Volumn 38, Issue 6, 1997, Pages 1204-1216

  Chiba, Hitoshi ^a   Akita, Harukuni ^a   Tsuchihashi, Keiko ^a,b   Hui, Shu Ping ^a   Takahashi, Yukihiro ^a   Fuda, Hirotoshi ^a   Suzuki, Haruki ^a   Shibuya, Hitoshi ^a   Tsuji, Masahiro ^c   Kobayashi, Kunihiko ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c Hokkaido Central Hospital for Social Health Insurance   (Japan)

Author keywords

apoA I; apoA II; Cholesterol; Dextran sulfate; Hyperalphalipoproteinemia; Low density lipoproteins; Phosphotungstate; Polyanion; Polyethylene glycol

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN; MACROGOL; PHOSPHOTUNGSTIC ACID;

ARTICLE; CHROMOSOME 16Q; EXON; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; QUANTITATIVE DIAGNOSIS;

ADULT; AGED; APOLIPOPROTEINS; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; COHORT STUDIES; GENOTYPE; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIAS; LIPIDS; MIDDLE AGED; POLYETHYLENE GLYCOLS; PRECIPITATION;

EID: 14444277710     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Morton, R. E., and D. B. Zilversmit. 1982. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J. Lipid Res. 23: 1058-1067.
2. Hesler, C. B., T. L. Swenson, and A. R. Tall. 1987. Purification and characterization of a human plasma cholesteryl ester transfer protein. J. Biol. Chem. 262: 2275-2285.
3. Lusis, A. J., S. Zollman, R. S. Sparkes, I. Klisak, T. Mohandas, D. Drayna, and R. M. Lawn. 1987. Assignment of the human gene for cholesteryl ester transfer protein to chromosome 16q12-16q21. Genomics. 1: 232-235.
4. Agellon, L. B., E. M. Quinet, T. G. Gillette, D. T. Drayna, M. L. Brown, and A. R. Tall. 1990. Organization of the human cholesteryl ester transfer protein gene. Biochemistiy. 29: 1372-1376.
5. Brown, M. L., A. Inazu, C. B. Hesler, L. B. Agellon, C. Mann, M. E. Whitlock, Y. L. Marcel, R. W. Milne, J. Koizumi, H. Mabuchi, R. Takeda, and A. R. Tall. 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoprotein. Nature. 342: 448-451.
6. Inazu, A., J. Koizumi, T. Haraki, K. Yagi, T. Wakasugi, T. Takegoshi, H. Mabuchi, and R. Takeda. 1993. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia. Hum. Genet. 91: 13-16.
7. Hirano, K., S. Yamashita, T. Funahashi, N. Sakai, M. Menju, M. Ishigami, H. Hiraoka, K. Kameda-Takeyama, K. Tokunaga, T. Hoshino, K. Kumasaka, K. Kawano, and Y. Matsuzawa. 1993. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population: relation between the mutation and hyperalphalipoproteinemia. Atherosclerosis. 100: 85-90.
8. Inazu, A., X.-C. Jiang, T. Haraki, K. Yagi, N. Kamon, J. Koizumi, H. Mabuchi, R. Takeda, K. Takata, Y. Moriyama, M. Doi, and A. R. Tall. 1994. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94: 1872-1882.
9. Akita, H., H. Chiba, K. Tsuchihashi, M. Tsuji, M. Kumagai, K. Matsuno, and K. Kobayashi. 1994. Cholesteryl ester transfer protein gene: two common mutations and their effect on plasma high density lipoprotein cholesterol content. J. Clin. Endocrinol. Metab. 79: 1615-1618.
10. Takahashi, K., X.-C. Jiang, N. Sakai, S. Yamashita, K. Hirano, H. Bujo, H. Yamazaki, J. Kusunoki, T. Miura, P. Kussie, Y. Matsuzawa, Y. Saito, and A. R. Tall. 1993. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoprotein. J. Clin. Invest. 92: 2060-2064.
11. Sakai, N., S. Yamashita, K. Hirano, M. Menju, T. Arai, K. Kobayashi, M. Ishigami, Y. Yoshida, T. Hoshino, N. Kameda-Takemura, and Y. Matsuzawa. 1995. Frequency of exon 15 missense mutation (442 D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis. 114: 139-145.
12. Gotoda, T., M. Kinoshita, H. Shimano, K. Harada, M. Shimada, J. Ohsuga, T. Teramoto, Y. Yazaki, and N. Yamada. 1993. Cholesteryl ester transfer protein gene deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. Biochem. Biophys. Res. Commun. 170: 1346-1351.
13. Akita, H., H. Chiba, S.-P. Hui, Y. Takahashi, K. Matsuno, and K. Kobayashi. 1995. Cholesteryl ester transfer protein deficiency: identification in the Chinese. Am. J. Med. Genet. 59: 399-400.
14. Funke, H., H. Wiebusch, L. Fuer, S. Muntoni, H. Schulte, and G. Assman. 1995. Identification of mutations in the cholesteryl ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation. 90: 1-240.
15. Bu, X., C. H. Warden, Y.-R. Xia, C. DeMeester, D. L. Puppione, S. Teruya, B. Lokensgard, S. Daneshmand, J. Brown, R. Gray, J. I. Rotter, and A. J. Lusis. 1994. Linkage analysis of the genetic determinants of high-density lipoprotein concentrations and compositions: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum. Genet. 93: 639-648.
16. Kondo, I., K. Berg, D. Drayna, and R. Lawn. 1989. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high-density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 35: 49-56.
17. Kessling, A., S. Ovellette, O. Bouffard, A. Chamberland, C. Bestard, E. Selinger, M. Xhignesse, S. Lusier-Cac, and J. Davignon. 1991. Patterns of association between genetic variability in apolipoprotein (apo) B, apoAI-CIII-ATV and cholesteryl ester transfer protein (CETP) gene region; and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones. Am. J. Hum. Genet. 50: 92-106.
18. Heiba, I. M., C. A. DeMeester, Y. R. Xia, A. Diep, V. T. George, C. T. Amos, S. R. Srinivasan, G. A. Berenson, R. C. Elston, and A. J. Lusis. 1993. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalosa Heart Study. Am. J. Med. Genet. 47: 875-883.
19. Savolainen, M. J., M. Hannuksela, S. Seppänen, K. Kervinen, and Y. A. Kesäniemi. 1990. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low transfer protein activity. Eur. J. Clin. Invest. 20: 593-599.
20. Kahri, J., P.-H. Groop, G. Viberty, T. Elliot, and M.-R. Taskinen. 1993. Regulation of apolipoprotein A-I-containing lipoproteins in IDDM. Diabetes 42: 1281-1288.
21. Sasaki, J., F. Hara, T. Motooka, S. Naito, and K. Arakawa. 1985. Nephrotic syndrome associated with hyper-high-density-lipoproteinemia potentiated by prednisolone therapy. Nephron. 41: 110-113.
22. Homma, Y., H. Ozawa, T. Kobayashi, H. Yamaguchi, H. Sakane, Y. Mikami, Y. Mikami, and H. Nakamura. 1995. Effects of bezafibrate therapy on subfractions of plasma low-density and high-density lipoproteins and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia. Atherosclerosis. 106: 191-201.
23. Homma, Y., H. Ozawa, T. Kobayashi, H. Yamaguchi, H. Sakane, H. Nakamura. 1995. Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Atherosclerosis. 114: 223-234.
24. Chiba, H., M. Eto, S. Fujisawa, K. Akizawa, S. Intoh, O. Miyata, K. Noda, K. Matsuno, and K. Kobayashi. 1993. Increased plasma apolipoprotein E-rich high-density lipoprotein cholesterol and its effect on serum high-density lipoprotein cholesterol determination in patients with familial hyperalphalipoproteinemia due to cholesteryl ester transfer activity deficiency. Biochem. Med. Metab. Biol. 49: 79-89.
25. Chiba, H., T. Osaka, N. Iwasaki, H. Suzuki, K. Akizawa, S. Fujisawa, S. Intoh, M. Watanabe, J. Yoshida, K. Matsuno, T. Mitamura, and K. Kobayashi. 1991. Spurious elevation of serum high-density lipoprotein cholesterol in patients with cholestatic liver diseases. Biochem. Med. Metab. Biol. 46: 329-343.
26. Umemori, S., H. Chiba, T. Moriyama, S. Takeda, H. Hosokawa, M. Nobuoka, M. Makino, M. Eto, and K. Akiyama. 1993. Elevation of serum apoE-rich HDL concentration in a patient with cholestatic liver disease. Jpn. J. Clin. Pathol. 41: 307-312. (English abstract)
27. Fujisawa, S., H. Chiba, K. Akizawa, S. Intoh, M. Watanabe, K. Matsuno, and K. Kobayashi. 1993. Rapid alteration in serum lipoprotein profile after bile drainage in a patient with acute bile duct obstruction: contribution of cholestasis to cholesteryl ester-dominant apoE-rich HDL accumulation. Jpn. J. Clin. Pathol. 41: 679-684. (English abstract)
28. Chiba, H., K. Akizawa, S. Fujisawa, T. Osaka-Nakamori, N. Iwasaki, H. Suzuki, S. Intoh, K. Matsuno, T. Mitamura, and K. Kobayashi. 1992. A rapid and simple quantificatin of human apolipoprotein E-rich high-density lipoprotein cholesterol in serum. Biochem. Med. Metab. Biol. 47: 31-37.
29. Iverius, P. H., and T. C. Laurent, 1967. Precipitation of some proteins by the addition of dextran or polyethylene glycol. Biochim. Biophys. Acta. 133: 371-373.
30. Viikari, J. 1976. Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J. Clin. Lab. Invest. 36: 265-268.
31. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
32. Albers, J. J., J. H. Tollefson, and C. H. Chen. 1984. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis. 4: 49-58
33. Mahley, R. W., D. Y. Hui, and T. L. Innerarity. 1981. Two independent lipoprotein receptors on hepatic membrane of dogs, swine, and man. J. Clin. Invest. 68: 1197-1206.
34. Desai, K., K. R. Bruckdorfer, R. A. Hutton, and J. Owen. 1989. Binding of apoE-rich high-density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J. Lipid. Res. 30: 831-840.
35. Higashihara, M., M. Kinoshita, T. Teramoto, S. Kume, and K. Kurokawa. 1991. The role of apoE in inhibitory effects of apoE-rich HDL on platelet function. FEBS Lett. 282: 82-86.
36. Wilson, H. M., J. C. Patel, D. Russel, and E. R. Skinner. 1993. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin. Chim. Acta. 220: 175-187.
37. Yamashita, S., D. Y. Hui, J. R. Wetterau, D. L. Sprecher, J. A. K. Harmony, N. Sakai, Y. Matsuzawa, and S. Tarui. 1991. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism. 40: 756-763.
38. Koizumi, J., H. Mabuchi, A. Yoshimura, I. Michishita, M. Takeda, H. Itoh, Y. Sakai, T. Sakai, K. Ueda, and R. Takeda. 1985. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia. Atherosclerosis. 58: 175-186.
39. Yamashita, S., D. L. Sprecher, N. Sakai, Y. Matsuzawa, S. Tarui, and D. Y. Hui. 1990. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J. Clin. Invest. 86: 688-695.
40. Mahley, R. W., and T. L. Innerarity. 1978. Properties of lipoproteins responsible for high affinity binding to cell surface receptors of fibroblasts and smooth muscle cells. In Drugs, Lipid Metabolism, and Atherosclerosis. D. Kritchevsky, R. Paoletti, and W. Holmes, editors. Plenum Publishing Corporation, New York, NY. 99-127.
41. Bury, J., and M. Rosseneu. 1985. Enzyme-linked immunosorbent assay for human apolipoprotein C-III. J. Clin. Chem. Clin. Biochem. 23: 63-68.
42. Weisgraber, K. H., and R. W. Mahley. 1980. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. J. Lipid Res. 21: 316-325.
43. 1 in the rat: effects of lipid transfer protein. J. Lipid Res. 28: 257-267.
44. Groener, J. E. M., T. van Gent, and A. van Tol. 1989. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholestesteryl ester in the rat. Biochim. Biophys. Acta. 1002: 93-100.
45. Ikewaki, K., D. J. Rader, T. Sakamoto, M. Nishiwaki, N. Wakimoto, J. R. Schaefer, T. Ishikawa, T. Fairwell, L. A. Zech, H. Nakamura, M. Nagano, and H. B. Brewer. 1993. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J. Clin. Invest. 92: 1650-1658.
46. Chiba, H., T. Mitamura, and H. Matsumiya. 1990. Sandwich enzyme-linked immunosorbent assay of rat apolipoprotein E. Biochem. Med. Metab. Biol. 43: 53-64.
47. Sakai, N., S. Yamashita, K. Hirano, M. Ishigami, T. Arai, K. Kobayashi, T. Funakoshi, and Y. Matsuzawa. 1995. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency. Eur. J. Clin. Invest. 25: 332-339.
48. Marcel, Y. L., R. McPherson, M. Hogue, H. Czarnecka, Z. Zawadzki, P. K. Weech, M. E. Whitlock, A. R. Tall, and R. W. Milne. 1990. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidemic subjects. J. Clin. Invest. 85: 10-17.
49. Moulin, P., M. C. Cheung, C. Bruce, S. Zhong, T. Cocke, H. Richardson, and A. R. Tall. 1994. Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein AT-defined lipoprotein subpopulations. J. Lipid Res. 35: 793-802.
50. Rye, K. A., K. H. Garrety, and P. J. Barter. 1992. Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins. J. Lipid Res. 33: 215-224.
51. Duverger, N., D. Rader, K. Ikewaki, M. Nishiwaki, T. Sakamoto, T. Ishikawa, M. Nagano, H. Nakamura, and H. B. Brewer. 1995. Characterization of high-density lipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency. Eur. J. Biochem. 227: 123-129.
52. Ohta, T., R. Nakamura, K. Takata, Y. Saito, S. Yamashita, S. Horiuchi, and I. Matsuda. 1995. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J. Lipid. Res. 36: 696-704.
53. Koizumi, J., A. Inazu, K. Yagi, I. Koizumi, Y. Uno, K. Kajinami, S. Miyamoto, P. Moulin, A. R. Tall, H. Mabuchi, and R. Takeda. 1991. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis. 90: 189-196.
54. Chajek, T., L. Aron, and C. J. Fielding. 1980. Interaction of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in the transport of cholesteryl ester into sphingomyelin liposomes. Biochemistry. 19: 3673-3677.
55. Manabe, M., T. Abe, M. Nozawa, A. Maki, M. Hirata, and H. Itakura. 1987. New substrate for determination of serum lecithin: cholesterol acyltransferase. J. Lipid Res. 28: 1206-1215.
56. Marcel, Y. L., C. Vezina, D. Emond, and G. Suzue. 1980. Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyl transferase. Pror. Natl. Acad. Sci. USA. 77: 2969-2973.
57. Burstein, M., H. R. Scholnick, and R. Morfin. 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11: 583-596.
58. Tall, A. R., E. Granot, R. Brocia, I. Tabas, C. Hesler, K. Williams, and M. Denke. 1987. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. J. Clin. Invest. 79: 1217-1225.
59. McPherson, R., C. J. Mann., A. R. Tall, M. Hogue, L. Martin, R. W. Milne, and Y. L. Marcel. 1991. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer activity and other lipoprotein variables. Arterioscler. Thromb. 11: 797-804.
60. Inazu, A., J. Koizumi, H. Mabuchi, K. Kajinami, and R. Takeda. 1992. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Horm. Metab. Res. 24: 284-288.